
Company News Release
Dr. Ross J. Horsburgh brings 20 Years of pharmaceutical and CRO experience in Asia/Pacific region to key leadership role.

Company News Release
Dr. Ross J. Horsburgh brings 20 Years of pharmaceutical and CRO experience in Asia/Pacific region to key leadership role.

Company News Release
Position to drive global business strategy required for successful delivery of early stage clinical trials.

Company News Release
Criterium announces a few new hires to keep up with increase in clinical studies.

Company News Release
Parexel hires Imogene Grimes, a leading biostatistician with more than 25 years of experience, as vice president of data sciences strategic services.

Applied Clinical Trials
Here are some of the things we took away from IIR's 17th Annual Partnerships with CROs and Other Outsourcing Providers Conference.


Applied Clinical Trials
A brief review of “A Quick Guide to Clinical Trials,” edited by Dr. Madhu Davies and Dr. Faiz Kermain.

Introducing Applied Clinical Trials’ new enewsletter, CRO News, which provides a forum for the industry to discuss the latest alliances, financial information, and business deals and developments, as well as people news.

Company News Release
ACORN expands market presence with commercialization of Guardian EDCT, the company’s electronic data capture system.

Company News Release
A partnership between Revolution Health and EmergingMed expands online services and helps match patients with the right clinical trials.

Company News Release
Brady introduces Labxpert v2.0 model to fulfill labeling requirements of the lab.

Company News Release
DSG is one of Ovation’s preferred providers for Phase I studies.

Company News Release
Nextrials’ revenues grow by 80 percent as industry adoption of Nextrial’ Prism accelerates, aided by growth in the medical device clinical trials market.

Company News Release
Logos Technologies and Exco InTouch integrate their EDC and SMS capabilities to speed up patient recruitment.

Company News Release
invivodata provides support to supplement approval of AMITIZA for irritable bowel syndrome with constipation in the United States.

Company News Release
Technology and services company Datatrak reports its 2008 first quarter results.

Company News Release
Former FDA Acting Commissioner and other industry experts to offer insight on turning Risk Evaluation and Mitigation Strategies theory into practice.

Company News Release
Latest version of ClearTrial software expands ability of life sciences organizations to accelerate the planning, execution, and outsourcing of clinical trials.

Company News Release
CTI Clinical Trial and Consulting Services and ASKA Research announce global collaboration in drug and medical device development, education services, and clinical trial management.

Company News Release
ACRO to collaborate with key stakeholders on efforts to enhance the clinical research enterprise.

Company News Release
Covance recognized for providing superior vaccine services to biopharmaceutical industry.

Company News Release
Mumbai investigative meeting conducted by Criterium, Inc. launches clinical study project in India for Thrombosis Research Institute.

Company News Release
Medidata’s clinical protocol authoring and trial design tool takes top honors in clinical trial and research category.

Company News Release
FDA will fill more than 1300 positions within the next several months.

Company News Release
SGS Opens Central & Eastern Europe Offices for Clinical Trial Management.

Company News Release
Clinsys Clinical Researchannounced the launch of Clinsys ALTERNA for customized Phase I–IV alternative solutions.

Applied Clinical Trials
CDISC and HL7 combine to create Biomedical Research Integrated Domain Group Model.

Subscribe to EDC News

Subscribe to Lab Views

Applied Clinical Trials
The Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland) received ?5 million from Spain's Agencia Espa?ola de Cooperaci?n Internacional, based in Madrid, to aid in the research and development of new, effective, and affordable drugs for neglected diseases, including Chagas disease, human African trypanosomiasis, and malaria. DNDi plans to develop two new malaria drugs by the end of the year and is looking to create between six and eight new drugs for neglected diseases by 2014.